CAS 216167-82-7

Succinobucol

Description:

Succinobucol is a synthetic compound primarily studied for its potential therapeutic applications, particularly in cardiovascular health. It is classified as a small molecule and is known for its antioxidant properties, which may help in reducing oxidative stress in biological systems. The compound has been investigated for its ability to lower levels of low-density lipoprotein (LDL) cholesterol, thereby potentially contributing to the management of hyperlipidemia and related cardiovascular conditions. Succinobucol's mechanism of action involves the inhibition of certain enzymes and pathways associated with lipid metabolism. Additionally, it has been noted for its relatively low toxicity profile in preclinical studies. However, like many investigational drugs, its clinical efficacy and safety profile require further validation through rigorous clinical trials. As with any pharmaceutical agent, the specific characteristics, including solubility, stability, and pharmacokinetics, are critical for its development and application in therapeutic settings.

Formula: C₃₅H₅₂O₅S₂

InChI: InChI=1S/C35H52O5S2/c1-31(2,3)23-17-21(18-24(29(23)39)32(4,5)6)41-35(13,14)42-22-19-25(33(7,8)9)30(26(20-22)34(10,11)12)40-28(38)16-15-27(36)37/h17-20,39H,15-16H2,1-14H3,(H,36,37)

InChI key: InChIKey=RKSMVPNZHBRNNS-UHFFFAOYSA-N

SMILES: O(C(CCC(O)=O)=O)C1=C(C(C)(C)C)C=C(SC(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)(C)C)C=C1C(C)(C)C

Synonyms:

• 4-[2,6-Di-Tert-Butyl-4-({2-[(3,5-Di-Tert-Butyl-4-Hydroxyphenyl)Sulfanyl]Propan-2-Yl}Sulfanyl)Phenoxy]-4-Oxobutanoic Acid
• Agi-1067
• Agz-1067
• Butanedioic acid, 1-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenyl] ester
• Butanedioic acid, mono[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenyl] ester
• Probucol monosuccinate
• Succinobucol

Butanedioic acid,1-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenyl]ester

CAS: 216167-82-7

Formula: C₃₅H₅₂O₅S₂

Purity: 99%

Color and Shape: Solid

Molecular weight: 616.9144

Ref: IN-DA007PRM

4-(2,6-Di-Tert-Butyl-4-((2-((3,5-Di-Tert-Butyl-4-Hydroxyphenyl)Thio)Propan-2-Yl)Thio)Phenoxy)-4-Oxobutanoic Acid

CAS: 216167-82-7

4-(2,6-Di-Tert-Butyl-4-((2-((3,5-Di-Tert-Butyl-4-Hydroxyphenyl)Thio)Propan-2-Yl)Thio)Phenoxy)-4-Oxobutanoic Acid

Purity: 99%

Molecular weight: 616.91g/mol

Ref: 54-OR1026333

Succinobucol

CAS: 216167-82-7

Succinobucol

Purity: ≥95%

Molecular weight: 616.91g/mol

Ref: 54-BUP13166

Succinobucol

CAS: 216167-82-7

Succinobucol is a phenolic antioxidant for treating heart atherosclerosis with anti-inflammatory effects.

Formula: C₃₅H₅₂O₅S₂

Purity: 97.47% - 99.96%

Color and Shape: Solid

Molecular weight: 616.91

Ref: TM-T4287

Succinobucol

CAS: 216167-82-7

Succinobucol is an experimental drug that may be used for the treatment of atherosclerotic lesions. It has been shown to inhibit the atp-binding cassette transporter and induce mitochondrial membrane potential, thereby inhibiting receptor activity in cardiac cells. This drug also inhibits toll-like receptor 4 (TLR4) expression and chemoattractant protein production, which may be responsible for its anti-inflammatory effects. Succinobucol has also been shown to inhibit ester linkages and enzymes involved in metabolic disorders, such as diabetes mellitus type 2.

Formula: C₃₅H₅₂O₅S₂

Purity: Min. 95 Area-%

Color and Shape: Powder

Molecular weight: 616.92 g/mol

Ref: 3D-FS27918

4-(2,6-di-tert-butyl-4-((2-((3,5-di-tert-butyl-4-hydroxyphenyl)thio)propan-2-yl)thio)phenoxy)-4-oxobutanoic acid

CAS: 216167-82-7

Purity: 99%

Molecular weight: 616.9199829

Ref: 10-F867198